Advaxis Inc. (NASDAQ:ADXS) Stock Suddenly Soars 28% Will The Rally Continue?

September 13, 2021

Advaxis Inc. (NASDAQ:ADXS) jumped 28% after announcing its Q3 2021 financial results and corporate update. During the quarter, the company signed a definitive merger agreement with Biosight Ltd with the proposed merger creating a public company that will operate as Biosight Therapeutics. The combined company will have cash, cash equivalents, and marketable securities of around $50 million at closing. Over the next 18 months, the combined company expects to report…

Read More >>

Advaxis Inc (ADXS) Stock Gains Momentum: How to Trade Now?

August 27, 2021

There has been no news about the biotech firm Advaxis Inc (NASDAQ:ADXS) in the past week but that has not stopped investors from piling on to the stock in droves. The trend was the same on Thursday as the Advaxis stock jumped by another 7% and took its gains over the course of the past week to as much as 20%. The rally in the stock may be related to…

Read More >>